In late 2015 when Ocata Therapeutics was acquired by Astellas Pharma, the company’s main area of focus was the development of human embryonic stem cell-derived retinal pigmented epithelial cells (RPEs) for treatment of multiple types of macular degeneration.
Ocata Therapeutics has patents on the preparation and use of hemangio-colony forming cells, erythroid cells from pluripotent stem cells, platelets from pluripotent stem cells, mesenchymal stromal cells, photoreceptor cells, RPE cells and pluripotent stem cells as well as modalities to treat degenerative diseases of the retina. Robert Lanza is named as inventor on all patents. Robert Lanza is Head of Astellas Global Regenerative Medicine and Chief Scientific Officer at the Astellas Institute for Regenerative Medicine.
Ocata Therapeutics changed its name to Astellas Institute for Regenerative Medicine (AIRM) in 2018. In a strategy to expand beyond ophthalmology and overcome the challenge of immunological rejection of transplanted cells Astellas acquired Universal Cells and will combine technologies of AIRM and Universal Cells.
Advanced Cell Technology Changes Name to Ocata Therapeutics
Astellas to Acquire Ocata Therapeutics
Documentaries, videos and podcasts
- Cluster: BiotechnologyA cluster of topics related to biotechnology.
- Cluster: Stem cell technologyTechnology used for isolating, generating, growing and controlling the differentiation of stem cells into specialized cells and the application of stem cell technology for medical and non-medical purposes such as producing meat through cellular agriculture.
- Stem cellStem cells are self-renewing cells that have the potential to become multiple different cell types in the body. Stem cells are found in developing embryos. Adult stem cells maintain and repair tissues throughout life. Induced pluripotent stem cells are a type of stem cell derived from adult cells that are reprogrammed in the lab.
- Regenerative medicineBranch of research dealing with the process of replacing, engineering, or regenerating biological units to (re-)establish normal function